Yubo International Biotech Ltd
Yubo International Biotech Ltd
BEIJING, F4
Loading...
Price History
Market Data
| Market Cap | 1.43M |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 0.24 |
| Currency | USD |
Key Financial Metrics
12,353.00
Revenue
-1.15M
Net Income
-
EPS (Diluted)
-1.59M
Free Cash Flow
Profitability
Gross Margin
66.1%
Operating Margin
-10625.8%
Net Profit Margin
-9334.4%
EBITDA
-1.10M
Returns & Efficiency
Return on Assets (ROA)
-136.1%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
-
Financial Health
Total Assets
847,094.00
Total Debt
-
Debt to Equity
-
Current Ratio
0.24
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Measuring, Analyzing & Controlling Instruments |
| HQ | BEIJING, F4 |
| Fiscal Year | 2025 |
Peers
100.03B
P/E: --
MEDTRONIC PLC
MDT
100.03B
P/E: --
MASIMO CORP
MASI
6.99B
P/E: --
3.32B
P/E: 20.3
LIVANOVA PLC
LIVN
3.21B
P/E: --
2.92B
P/E: 35.5
LECTEC CORP /MN/
AXGN
2.32B
P/E: --
AXOGEN, INC.
AXGN
2.32B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$1.43M
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin66.1%
Operating Margin-10625.8%
Net Margin-9334.4%
ROE-
ROA-136.1%
Leverage & Liquidity
Debt to Equity-
Current Ratio0.24
Total Debt-
Total Assets$847.09K
Stockholders' Equity$-1.95M
Income Statement (FY 2025)
Revenue$12.35K
Gross Profit$8.16K
Operating Income$-1.31M
Net Income$-1.15M
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$-1.59M
Cash & Equivalents$8.06K
Revenue Growth256.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING, F4 00000 |
| Phone | N/A |
| Incorporated | NY, US |
| EIN | 113074326 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 170.42M |
| Stockholders' Equity | $-1.95M |
| Cash & Equivalents | $8.06K |
Recent Filings
View All
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-03-31
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-14
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-03-31
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-13
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-19
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-20
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-04-12
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-11-20
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-08-11
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-05-15
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2023-04-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2022-11-16
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2022-08-15
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | Yubo International Biotech Ltd |
| Ticker | YBGJ |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Measuring, Analyzing & Controlling Instruments |
| Headquarters | BEIJING, F4 |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 1.43M |
| Revenue | 12,353.00 |
| Net Income | -1.15M |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -9334.4% |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...